SCHEMBL3785366

SCHEMBL3785366

Cc1cc(Nc2ncnc3cc(C(F)(F)F)ccc23)n[nH]1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.56
NTRK1 P04629 3/20 0.56
NTRK3 Q16288 1/20 0.56
NTRK2 Q16620 1/20 0.56
SYK P43405 2/20 0.51
EGFR P00533 5/20 0.48
AURKA O14965 6/20 0.46
ABCG2 Q9UNQ0 2/20 0.45
TRPV1 Q8NER1 2/20 0.45
AURKB Q96GD4 4/20 0.45
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
SRC P12931 2/20 0.44
GSK3B P49841 2/20 0.44
EIF2AK2 P19525 1/20 0.44
GSK3A P49840 1/20 0.44
GAK O14976 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3791195 0.82 DHODH (0.55) DHODHNTRK1NTRK3NTRK2SYK
SCHEMBL29997075 0.79 AURKA (0.62) NTRK1EGFRAURKAAURKBSRC
SCHEMBL17666782 0.78 NTRK1 (0.61) DHODHNTRK1NTRK3NTRK2SYK
SCHEMBL3774652 0.78 NTRK1 (0.59) DHODHNTRK1NTRK3NTRK2SYK
SCHEMBL5740105 0.76 EGFR (0.69) EGFRABCG2TRPV1TSHRHTT
SCHEMBL30379763 0.74 FGFR2 (0.71) SYKEGFRAURKAAURKB
SCHEMBL30482729 0.74 NTRK1 (0.75) NTRK1NTRK3NTRK2AURKAAURKB
SCHEMBL5739477 0.74 EGFR (0.49) EGFRABCG2TRPV1TSHRHTT
SCHEMBL11088081 0.74 EGFR (0.69) EGFRABCG2TRPV1AURKBTSHR
SCHEMBL31037444 0.74 FGFR2 (0.67) NTRK1SYKAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611502-A1 ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP claimed
WO-2012030918-A1 ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO claimed
WO-2010099379-A1 JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2010-09-02 WO claimed